Concentric Capital Strategies LP Sells 32,651 Shares of BWX Technologies, Inc. $BWXT

Concentric Capital Strategies LP cut its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT) by 60.2% during the fourth quarter, Holdings Channel reports. The fund owned 21,578 shares of the technology company’s stock after selling 32,651 shares during the quarter. Concentric Capital Strategies LP’s holdings in BWX Technologies were worth $3,730,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in BWXT. Clough Capital Partners L P boosted its position in BWX Technologies by 526.5% during the fourth quarter. Clough Capital Partners L P now owns 99,610 shares of the technology company’s stock worth $17,217,000 after purchasing an additional 83,710 shares during the period. Bamco Inc. NY acquired a new stake in shares of BWX Technologies during the 4th quarter worth about $148,000. Boothbay Fund Management LLC bought a new stake in shares of BWX Technologies during the 4th quarter worth about $221,000. Bridgeway Capital Management LLC acquired a new position in BWX Technologies in the 4th quarter valued at about $2,610,000. Finally, Altshuler Shaham Ltd raised its holdings in BWX Technologies by 8.4% in the 4th quarter. Altshuler Shaham Ltd now owns 4,518 shares of the technology company’s stock valued at $781,000 after acquiring an additional 351 shares during the period. Institutional investors own 94.39% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on BWXT. BTIG Research boosted their price objective on BWX Technologies from $225.00 to $235.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. TD Securities assumed coverage on BWX Technologies in a report on Thursday, March 12th. They set a “buy” rating and a $230.00 price target for the company. Wells Fargo & Company initiated coverage on BWX Technologies in a report on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price objective on the stock. TD Cowen initiated coverage on BWX Technologies in a research report on Thursday, March 12th. They set a “buy” rating and a $230.00 price objective on the stock. Finally, Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $228.00.

Insider Transactions at BWX Technologies

In other BWX Technologies news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $209.25, for a total value of $505,757.25. Following the transaction, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at $1,440,477. This trade represents a 25.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

BWX Technologies Trading Up 3.1%

Shares of NYSE:BWXT opened at $203.11 on Thursday. The business’s 50 day simple moving average is $208.48 and its 200 day simple moving average is $200.66. BWX Technologies, Inc. has a 1 year low of $133.84 and a 1 year high of $241.82. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. The company has a market capitalization of $18.61 billion, a P/E ratio of 54.31, a P/E/G ratio of 3.24 and a beta of 0.73.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings data on Monday, May 4th. The technology company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.20. The firm had revenue of $860.22 million during the quarter, compared to analysts’ expectations of $837.47 million. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The company’s quarterly revenue was up 26.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, research analysts anticipate that BWX Technologies, Inc. will post 4.71 EPS for the current fiscal year.

BWX Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Tuesday, May 19th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Tuesday, May 19th. This represents a $1.08 annualized dividend and a yield of 0.5%. BWX Technologies’s dividend payout ratio is currently 28.88%.

BWX Technologies Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.